Fri, April 8, 2022
Thu, April 7, 2022
Wed, April 6, 2022
Tue, April 5, 2022
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022

Derek Archila Initiated (ZNTL) at Buy and Held Target at $67 on, Apr 6th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-67-on-apr-6th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Wells Fargo, Initiated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy and Held Target at $67 on, Apr 6th, 2022.

Derek has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Derek's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Derek


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $94 on, Thursday, January 20th, 2022
  • Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $97 on, Friday, December 17th, 2021

Publication Contributing Sources